Annual New York Lung Cancers Symposium

The Annual New York Lung Cancers Symposium, now in its 21st year, offers a robust platform for healthcare professionals to enhance their understanding and management of lung cancer. This symposium takes place at the New York Hilton Midtown in New York, United States, and is tailored for a diverse audience that includes medical oncologists, surgeons, radiologists, general scientists, young investigators, advanced practice providers, nurses, and pharmacists who are involved in the care of lung cancer patients.

The event also welcomes other healthcare professionals who have an interest in the treatment of lung cancer, broadening its impact across the medical community.

Attendees will benefit from a comprehensive overview of multidisciplinary lung cancer treatment, focusing on the critical roles of surgery, radiology, pulmonology, and pathology in achieving accurate diagnoses. Key thought leaders from the New York area will present optimal strategies for managing early-stage and locally advanced lung cancers, as well as share the latest findings on immunotherapy and targeted agents for metastatic lung cancers.

The symposium will feature an engaging tumor board format, allowing participants to present clinical challenges and ask questions that address real-world scenarios in lung cancer treatment. Furthermore, a special session designed specifically for nurse practitioners and physician assistants will provide a tailored learning and networking experience, reinforcing the symposium's commitment to multidisciplinary education.